Filings

4 documents · 22 matches

1. GOSS Gossamer Bio, Inc. 10-Q 2026-11-10

   Item 1 · Note 5. Indebtedness

   going concern disclosed in Note 1 – Liquidity and Going Concern, the Company evaluated the Exchange Offer under ASC 470-60, Troubled
   5 matches in this document Show context Copy citation

2. GOSS Gossamer Bio, Inc. 10-Q 2026-08-13

   Item 1 · Note 5. Indebtedness

   going concern disclosed in Note 1 – Liquidity and Going Concern, the Company evaluated the Exchange Offer under ASC 470-60, Troubled
   5 matches in this document Show context Copy citation

3. GOSS Gossamer Bio, Inc. 10-Q 2026-05-15

   Item 1 · Note 1. Description of Business

   going concern. The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
   4 matches in this document Show context Copy citation

4. GOSS Gossamer Bio, Inc. 10-K 2026-03-17

   Item 16. Form 10–K Summary.

   going concern. As discussed in Note 1 to the financial statements, the Company has suffered recurring losses from operations and has stated
   8 matches in this document Show context Copy citation